Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer

Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their behavior is regulated through a complex interplay of networks, including transcriptional, post-transcriptional, epigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhen, Fu, Minyang, Hu, Yuan, Wei, Yuquan, Wei, Xiawei, Luo, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583419/
https://www.ncbi.nlm.nih.gov/pubmed/37853437
http://dx.doi.org/10.1186/s12943-023-01877-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583419/
https://www.ncbi.nlm.nih.gov/pubmed/37853437
http://dx.doi.org/10.1186/s12943-023-01877-w

Ejemplares similares